Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Epidosin
2. N,n-diethyl-n-methyl-2-(3-methyl-2-phenylvaleryloxy)ethylammonium Bromide
3. Valethamate Bromide
1. Valethamate Ion
2. Valethamate Cation
3. 16376-74-2
4. D64s64qvx7
5. Murel
6. N,n-diethyl-n-methyl-2-(3-methyl-2-phenylvaleryloxy)ethylammonium
7. Ethanaminium, N,n-diethyl-n-methyl-2-((3-methyl-1-oxo-2-phenylpentyl)oxy)-
8. N,n-diethyl-n-methyl-2-((3-methyl-1-oxo-2-phenylpentyl)oxy)ethanaminium
9. Epidosan
10. Ncgc00185757-01
11. Unii-d64s64qvx7
12. Letamate
13. Velamate
14. Elist
15. Release V
16. Valethamate [who-dd]
17. Schembl249537
18. Chembl2111176
19. Dtxsid40859155
20. Chebi:135303
21. Diethyl-methyl-[2-(3-methyl-2-phenylpentanoyl)oxyethyl]azanium
22. Db13497
23. Q27276155
24. Diethyl-methyl-[2-(3-methyl-2-phenyl-pentanoyl)oxyethyl]ammonium
25. N,n-diethyl-n-methyl-2-[(3-methyl-2-phenylpentanoyl)oxy]ethan-1-aminium
26. Ammonium, Diethyl(2-hydroxyethyl)methyl-, 3-methyl-2-phenylvalerate (ester) (8ci)
27. Ethanaminium, N,n-diethyl-n-methyl-2-[(3-methyl-1-oxo-2-phenylpentyl)oxy]-, Bromide
| Molecular Weight | 306.5 g/mol |
|---|---|
| Molecular Formula | C19H32NO2+ |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 10 |
| Exact Mass | 306.243304264 g/mol |
| Monoisotopic Mass | 306.243304264 g/mol |
| Topological Polar Surface Area | 26.3 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 1 |
| Complexity | 319 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AX - Other drugs for functional gastrointestinal disorders
A03AX14 - Valethamate
Market Place
ABOUT THIS PAGE
19
PharmaCompass offers a list of Valethamate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Valethamate manufacturer or Valethamate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Valethamate manufacturer or Valethamate supplier.
PharmaCompass also assists you with knowing the Valethamate API Price utilized in the formulation of products. Valethamate API Price is not always fixed or binding as the Valethamate Price is obtained through a variety of data sources. The Valethamate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Velamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Velamate, including repackagers and relabelers. The FDA regulates Velamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Velamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Velamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Velamate supplier is an individual or a company that provides Velamate active pharmaceutical ingredient (API) or Velamate finished formulations upon request. The Velamate suppliers may include Velamate API manufacturers, exporters, distributors and traders.
click here to find a list of Velamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Velamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Velamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Velamate GMP manufacturer or Velamate GMP API supplier for your needs.
A Velamate CoA (Certificate of Analysis) is a formal document that attests to Velamate's compliance with Velamate specifications and serves as a tool for batch-level quality control.
Velamate CoA mostly includes findings from lab analyses of a specific batch. For each Velamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Velamate may be tested according to a variety of international standards, such as European Pharmacopoeia (Velamate EP), Velamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Velamate USP).
